NVSEF News and Press, Novartis Ag Basel Akt From 09/17/20

Quick Take Taysha Gene Therapies ( TSHA ) has filed to raise $125 million in an IPO of its common stock, according to an S-1 registration statement . The company is developing genetic therapy treatments for various neurodegenerative diseases and other disorders. TSHA is still at a precl...

Quick Take Virios Therapeutics ( VIRI ) has filed to raise $34.5 million in an IPO of its common stock, according to an S-1 registration statement . The company is developing a drug treatment for fibromyalgia, a nerve pain condition. VIRI has generated interesting early stage efficacy r...

The following slide deck was published by Novartis AG in conjunction with this Read more ...

BioMarin ( BMRN ) received a complete response letter or CRL for their hemophilia A gene therapy Valrox last week. As a result, the earliest commercial launch is now in 2023. Audentes ( ALPMF ) provided an update on their please 3 neuromuscular ASPIRO clinical trial indicating a third pati...

Background - Liking the setup Novo Nordisk ( NVO ) is trading at a 23X TTM P/E. This is below that of the S&P 500 ( SPY ) - of which it cannot be a member as a Danish company - which is now at 24X peak (CY 2019) GAAP EPS of $139, and a much higher P/E based on current earnings. Unlike mo...

Genomic medicine, the next major biotech era, is primarily pre-commercial though a few medicines have been approved. The list of FDA-approved cellular and gene therapy products did increase in July when the second Kite Pharma ( GILD ) cell therapy - Tecartus - was approved for relapsed/refract...

This article is part of a series that provides an ongoing analysis of the changes made to Tweedy Browne’s 13F portfolio on a quarterly basis. It is based on Tweedy Browne’s regulatory 13F Form filed on 08/11/2020. Please visit our Tracking Tweedy Browne Portfolio series to ge...

The art of medicine consists of amusing the patient while nature cures the disease. ― Voltaire At first glance, Tekla World Healthcare Fund ( THW ) looks like a solid dividend bet because it has been paying dividends consistently since inception and it sports an attractive dividend ...

Original post Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...

Quick Take Checkmate Pharmaceuticals ( CMPI ) intends to raise $75 million from the sale of its common stock stock in an IPO, according to an amended registration statement . The company is advancing a biologic particle treatment for melanomas and head & neck squamous cell carcinomas....